invigor semaglutide WEIGHT LOSS Ozempic and Wegovy weight loss

Anderson, FASAE, CAE, IOM President & Chief Executive Officer Date: June 4, 2026 Beginning July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) will launch the Medicare GLP-1 Bridge Program, a temporary demonstration designed to provide

Exciting updates in the world of GLP-1s

Truveta Research tracks GLP-1 RA prescribing through March 2026, showing accelerated anti-obesity use and a sharp rise in first-time semaglutide prescribing.

Ozempic & Wegovy companion

Discover how Tirzepatide goes beyond weight loss to protect brain health

Developing drugs for metabolic dysfunction-associated steatohepatitis (MASH) has been a surprisingly challenging task